These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36708155)

  • 1. Triglyceride-glucose index is associated with metabolic syndrome in women with polycystic ovary syndrome.
    Yang H; Chen Y; Liu C
    Gynecol Endocrinol; 2023 Dec; 39(1):2172154. PubMed ID: 36708155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of the triglyceride-glucose index and non-traditional blood lipid parameters in predicting metabolic syndrome in women with polycystic ovary syndrome.
    Zhang L; Wang H; Ma Q; Liu Y; Chen A; Lu J; Ren L
    Hormones (Athens); 2023 Jun; 22(2):263-271. PubMed ID: 36790635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neck circumference is independently associated with metabolic syndrome in women with polycystic ovary syndrome.
    Liu C; Ding L; Yang H; Chen Z
    Endocr J; 2022 Jul; 69(7):809-818. PubMed ID: 35173107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The discriminative ability of the triglyceride-glucose index to identify metabolic syndrome among adults of the northern Sri Lankan population.
    Paramanathan T; Sandrasegarampillai B; Arasaratnam V; Thirunavukarasu K
    BMC Endocr Disord; 2024 Jul; 24(1):101. PubMed ID: 38951832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome in Greek women with polycystic ovary syndrome: prevalence, characteristics and associations with body mass index. A prospective controlled study.
    Kyrkou G; Trakakis E; Attilakos A; Panagopoulos P; Chrelias C; Papadimitriou A; Vaggopoulos V; Alexiou E; Mastorakos G; Lykeridou A; Kassanos D; Papaevangelou V; Papantoniou N
    Arch Gynecol Obstet; 2016 Apr; 293(4):915-23. PubMed ID: 26615602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of lipid ratios and triglyceride-glucose index as risk markers of insulin resistance in Iranian polycystic ovary syndrome women.
    Kheirollahi A; Teimouri M; Karimi M; Vatannejad A; Moradi N; Borumandnia N; Sadeghi A
    Lipids Health Dis; 2020 Nov; 19(1):235. PubMed ID: 33161896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of sex hormone-binding globulin on predicting metabolic syndrome in newly diagnosed and untreated patients with polycystic ovary syndrome.
    Fu C; Minjie C; Weichun Z; Huihuang Y; Guishan C; Qingxia H; Xiaoping Y; Lan C; Ping W; Chujia L; Guoshu Y
    Hormones (Athens); 2020 Sep; 19(3):439-445. PubMed ID: 32562143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome in Mediterranean women with polycystic ovary syndrome: when and how to predict its onset.
    Espinós-Gómez JJ; Rodriguez-Espinosa J; Ordóñez-Llanos J; Calaf-Alsina J
    Gynecol Endocrinol; 2012 Apr; 28(4):264-8. PubMed ID: 21962027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adiponectin/(FBG × FIns) as a predictor of insulin sensitivity and metabolic syndrome in patients with polycystic ovary syndrome.
    Xu X; Lai Y; Yang G; Yang M; Li L; Zhang Q; Liu H; Zheng H; Zhu D
    Medicine (Baltimore); 2016 Dec; 95(49):e5524. PubMed ID: 27930544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of metabolic syndrome is higher among non-obese PCOS women with hyperandrogenism and menstrual irregularity in Korea.
    Kim MJ; Lim NK; Choi YM; Kim JJ; Hwang KR; Chae SJ; Park CW; Choi DS; Kang BM; Lee BS; Kim T; Park HY
    PLoS One; 2014; 9(6):e99252. PubMed ID: 24901345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
    Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
    J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superiority of the triglyceride glucose index over the homeostasis model in predicting metabolic syndrome based on NHANES data analysis.
    Wan H; Cao H; Ning P
    Sci Rep; 2024 Jul; 14(1):15499. PubMed ID: 38969755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The natural logarithm of zinc-α2-glycoprotein/HOMA-IR is a better predictor of insulin sensitivity than the product of triglycerides and glucose and the other lipid ratios.
    Qu C; Zhou X; Yang G; Li L; Liu H; Liang Z
    Cytokine; 2016 Mar; 79():96-102. PubMed ID: 26797477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of polycystic ovary syndrome in Chinese obese women of reproductive age with or without metabolic syndrome.
    Liang P; Xi L; Shi J; Li W; Zhao S; Deng Y; Wang R; Sun Y; Gu B; Yuan L; Zhang Y; Gu W; Wang W; Hong J
    Fertil Steril; 2017 Apr; 107(4):1048-1054. PubMed ID: 28238496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A visceral adiposity index-related dietary pattern and the cardiometabolic profiles in women with polycystic ovary syndrome.
    Ehsani B; Moslehi N; Mirmiran P; Ramezani Tehrani F; Tahmasebinejad Z; Azizi F
    Clin Nutr; 2016 Oct; 35(5):1181-7. PubMed ID: 26699405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Apolipoprotein B/A1 Ratio is Associated With Metabolic Syndrome Components, Insulin Resistance, Androgen Hormones, and Liver Enzymes in Women With Polycystic Ovary Syndrome.
    He H; Feng J; Zhang S; Wang Y; Li J; Gao J; Cong J; Gong Y; Wu X
    Front Endocrinol (Lausanne); 2021; 12():773781. PubMed ID: 35069437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triglycerides as a Metabolic Target in Afrocaribbean Infertile Women with Polycystic Ovary Syndrome.
    Brouzeng C; Bachelot A; Moriniere C; Vaillant J; Joguet G; Velayoudom FL
    Metab Syndr Relat Disord; 2019 Dec; 17(10):500-504. PubMed ID: 31592705
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome.
    Cheung LP; Ma RC; Lam PM; Lok IH; Haines CJ; So WY; Tong PC; Cockram CS; Chow CC; Goggins WB
    Hum Reprod; 2008 Jun; 23(6):1431-8. PubMed ID: 18359783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome and the risk of cardiovascular complications in young patients with different phenotypes of polycystic ovary syndrome.
    Krentowska A; Łebkowska A; Jacewicz-Święcka M; Hryniewicka J; Leśniewska M; Adamska A; Kowalska I
    Endocrine; 2021 May; 72(2):400-410. PubMed ID: 33442790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome.
    Soares EM; Azevedo GD; Gadelha RG; Lemos TM; Maranhão TM
    Fertil Steril; 2008 Mar; 89(3):649-55. PubMed ID: 17543961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.